The window of opportunity in ACPA-positive rheumatoid arthritis is not explained by ACPA characteristics

被引：6

作者：

Willemze, Annemiek ^{[1
]}

van der Linden, Michael P. M. ^{[1
]}

le Cessie, Saskia ^{[2
,3
]}

Trouw, Leendert A. ^{[1
]}

Toes, Rene E. M. ^{[1
]}

Huizinga, Tom W. J. ^{[1
]}

van der Helm-van Mil, Annette H. M. ^{[1
]}

机构：

[1] Leiden Univ, Dept Rheumatol, Med Ctr, NL-2300 RC Leiden, Netherlands

[2] Leiden Univ, Dept Clin Epidemiol, Med Ctr, NL-2300 RC Leiden, Netherlands

[3] Leiden Univ, Dept Med Stat & Bioinformat, Med Ctr, NL-2300 RC Leiden, Netherlands

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2011年 / 70卷 / 09期

关键词：

CITRULLINATED PROTEIN ANTIBODY; FINE SPECIFICITY; SHARED EPITOPE; DISEASE; THERAPY; DELAY;

D O I：

10.1136/ard.2010.148312

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1697 / U401

页数：2

共 11 条

[1] Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? [J].

de Rooy, Diederik P. C. ;

van der Linden, Michael P. M. ;

Knevel, Rachel ;

Huizinga, Tom W. J. ;

van der Helm-van Mil, Annette H. M. .

RHEUMATOLOGY, 2011, 50 (01) :93-100

[2]

Green M, 1999, ARTHRITIS RHEUM, V42, P2184, DOI 10.1002/1529-0131(199910)42:10<2184::AID-ANR20>3.0.CO

[3]

2-2

[4] Marked Differences in Fine Specificity and Isotype Usage of the Anti-Citrullinated Protein Antibody in Health and Disease [J].

Ioan-Facsinay, Andreea ;

Willemze, Annemiek ;

Robinson, David B. ;

Peschken, Christine A. ;

Markland, Janet ;

van der Woude, Diane ;

Elias, Brenda ;

Menard, Henri A. ;

Newkirk, Marianna ;

Fritzler, Marvin J. ;

Toes, Rene E. M. ;

Huizinga, Tom W. J. ;

El-Gabalawy, Hani S. .

ARTHRITIS AND RHEUMATISM, 2008, 58 (10) :3000-3008

[5] Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis [J].

Möttönen, T ;

Hannonen, P ;

Korpela, M ;

Nissilä, M ;

Kautiainen, H ;

Ilonen, J ;

Laasonen, L ;

Kaipiainen-Seppänen, O ;

Franzen, P ;

Helve, T ;

Koski, J ;

Gripenberg-Gahmberg, M ;

Myllykangas-Luosujärvi, R ;

Leirisalo-Repo, M .

ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :894-898

[6] Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis [J].

Nell, VPK ;

Machold, KP ;

Eberl, G ;

Stamm, TA ;

Uffmann, M ;

Smolen, JS .

RHEUMATOLOGY, 2004, 43 (07) :906-914

[7]

Quinn MA, 2003, CLIN EXP RHEUMATOL, V21, pS154

[8] Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis [J].

Rantapää-Dahlqvist, S ;

de Jong, BAW ;

Berglin, E ;

Hallmans, G ;

Wadell, G ;

Stenlund, H ;

Sundin, U ;

van Venrooij, WJ .

ARTHRITIS AND RHEUMATISM, 2003, 48 (10) :2741-2749

[9] Long-Term Impact of Delay in Assessment of Patients With Early Arthritis [J].

van der Linden, Michael P. M. ;

Le Cessie, Saskia ;

Raza, Karim ;

van der Woude, Diane ;

Knevel, Rachel ;

Huizinga, Tom W. J. ;

van der Helm-van Mil, Annette H. M. .

ARTHRITIS AND RHEUMATISM, 2010, 62 (12) :3537-3546

[10] Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis [J].

van der Woude, Diane ;

Dahlqvist, Solbritt Rantapaa ;

Ioan-Facsinay, Andreea ;

Onnekink, Carla ;

Schwarte, Carla M. ;

Verpoort, Kirsten N. ;

Drijfhout, Jan W. ;

Huizinga, Tom W. J. ;

Toes, Rene E. M. ;

Pruijn, Ger J. M. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) :1554-1561

← 1 2 →